Research programme: liver X receptor modulators - Roche

Drug Profile

Research programme: liver X receptor modulators - Roche

Alternative Names: T 0901317

Latest Information Update: 12 Dec 2008

Price : $50

At a glance

  • Originator Roche
  • Class Sulfonamides
  • Mechanism of Action Liver X receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Alzheimer's disease

Most Recent Events

  • 21 Jul 2006 Preclinical trials in Alzheimer's disease in Switzerland (unspecified route)
  • 21 Jul 2006 Data presented at the 10th International Conference on Alzheimer's Disease and Related Disorders (ICAD-2006) have been added to the Alzheimer's disease pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top